Summary
Group 1 prostate cancer is common, usually not lethal and requires active surveillance.
-rl024j3vqecx.jpg)
Prostate cancer is reasonably common in men and about one in six will be diagnosed with the disease at a certain point in life. But these tumors are usually not fatal.
“Most of the newly diagnosis men have a prostate carrinoma of group 1 (GG1), which can remain for years without causing significant damage. Prostate cancer is classified according to what has been spread and how aggressive it seems to be under a microscope. Pure prostate carcinoma is the least risky form of the disease. It often occurs with age, it does not metastal to other parts of the body and does not require any immediate treatment. If treated, his healing rates are 99%”, explains Ramon Andrade de Mello, oncologist of San Paolo, vice-president of the Brazilian Cancerology Society, post-clinical post-media at the Royal Marsden Nhs Foundation Trust (England) and Honorary Researcher at Oxford University University (England).
Since it is more “mild”, in the medical community there is a debate that it would be right to change the name of the disease, rather than calling the “cancer”. But does it really make sense? According to the vice -president of the Brazilian Cancerology Society, n.
“I agree that those low -risk prostate tumors usually do not threaten the life of patients. However, you say it shouldn’t be called cancer is a bit complicated. They must also be followed closely and carefully. Furthermore, if we delimit that only high risk cancer should be called cancer, we further increase the stigma on that word “, explains the doctor.
Many doctors claim to change their nomenclature due to the stigma of the word “cancer” who brings many men to anxiety paintings.
“Cancer GG1 is generally revealed by the PSA monitoring. The objective of monitoring is to find more aggressive prostate cancer while it is still curable, but these efforts often detect GG1 cancer by engraved, “says the doctor.
“The debate does not revolve around the disease, but to treat it with active supervision. With this standard practice, doctors monitor the disease with PSA test periodicals, biopsies and imaging exams and treat the disease only if it shows signs of progression “, explains the expert.
“But also while medical groups work to promote active surveillance, many men with low -risk prostate cancer are immediately treated to the insistence of patients, who have a very strong emotional impact on the diagnosis of cancer”, underlines the oncologist of San Paolo.
The doctor explains that a consequence is an excessive widespread treatment, with tens of thousands of men subjected to unnecessarily side effects of surgery or radiation every year. “However, it is essential that the doctor instructs the patient or not drawing the treatment. This is more prudent, “explains the oncologist.
The doctors, in particular from the United States, proposed that this tumor was called acareare neoplasm, which is an abnormal but not lethal growth in the tissue. “But this can have a negative effect as it can cause patients to abandon active surveillance if they are not informed that they have cancer,” says the expert.
“And monitoring the condition with active surveillance is crucial. In addition, men with a strong family history of cancer or genetic mutations such as BRCA1 and BRCA2 who put them at greater risk of aggressive diseases, should be followed more closely “, concludes Ramon Andrade de Mello.
It inspires the transformation into the world of work, business, society. It is the creation of the compass, content and the connection agency.
Source: Terra
Ben Stock is a lifestyle journalist and author at Gossipify. He writes about topics such as health, wellness, travel, food and home decor. He provides practical advice and inspiration to improve well-being, keeps readers up to date with latest lifestyle news and trends, known for his engaging writing style, in-depth analysis and unique perspectives.
